When you prepare for childbirth, you are likely told about labor pain, cesarean delivery, and common newborn screenings. Far fewer conversations focus on hypoxic ischemic encephalopathy, often called ...

Professor of Pathology, Lee J. Martin, discusses the prevalence and treatment challenges associated with hypoxic-ischemic encephalopathy (HIE), and his research that aims to identify new treatment ...

Abstract: Hypoxic-Ischemic Encephalopathy (HIE) is caused by inadequate blood flow and oxygen delivery to the brain, typically occurring around the time of birth. In the Neonatal Unit, neonates with ...

AAP updated guidance supports therapeutic hypothermia for term infants with moderate to severe HIE, emphasizing early initiation and specialized care. Neonatal HIE is a form of brain injury caused by ...

Abstract: Hypoxic Ischemic Encephalopathy (HIE) represents a brain dysfunction, affecting approximately 1 to 5 per 1000 full-term neonates. The precise delineation and segmentation of HIE-related ...

PHOENIX — A Valley hospital is being sued after a newborn allegedly sustained a brain injury while being delivered. Mignonette Aleta Reyes and Nestor Aguilar filed the lawsuit on Oct. 31 on behalf of ...

Medical malpractice: Suit alleges that medical staff's negligent care during childbirth resulted in hypoxic-ischemic injuries to an infant's brain and vital organs, failing to meet required standards ...

NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to ...

Data confirm elevated inflammatory biomarkers in newborns with Hypoxic Ischemic Encephalopathy (HIE) and demonstrate a predictable pharmacokinetic profile for RLS-0071 (pegtarazimod) NORFOLK, ...

In addition, data presented at PAS revealed a predictable pharmacokinetic profile in the newborn population, consistent with adult humans. Findings from the ongoing STAR trial (NCT05778188) provided ...